Hemealumen TS: Revolutionary Polychromatic Photobiomodulation System

Revolutionary Polychromatic Photobiomodulation System

The Hemealumen TS Polychromatic Device is a cutting-edge, minimally invasive photoluminescence blood treatment system designed to combat auto-immune, viral, bacterial, and fungal diseases. It is also effective for treating similar conditions in pets, including dogs and cats. This advanced device enhances patient outcomes by utilizing light-based therapy to stimulate the body's natural healing processes.

Immediate Clinical Impact

• Immediate Impact: Complete resolution of dengue/zika in 48 hours. 55/55 malaria cases resolved in 2 days. Zero COVID-19 mortality with 7-day reduced hospital stays.
• Proven Safety: Over 80 years of clinical use with >95% success rates across 6,500+ patients. Zero adverse effects reported in 200+ peer-reviewed studies.
• Revolutionary Technology: Patented TRIVETTE™ design increases blood exposure time by 600% compared to traditional devices, delivering superior therapeutic outcomes through polychromatic wavelength integration.

How Hemealumen TS Works: Advanced Polychromatic Precision

Patented TRIVETTE™ Triple Quartz Tube Design

The revolutionary triple-tube parallel arrangement extends blood exposure time by 600%, ensuring comprehensive pathogen inactivation and optimal cellular activation. This patented design represents the first significant advancement in UVBI technology.

Targeted Pulsed Frequencies

Proprietary frequency modulation similar to Rife technology ensures precise cellular targeting while maximizing therapeutic efficacy across multiple biological systems.

Transform Patient Outcomes

Six-Wavelength Polychromatic System

• UVC 253.7nm: Direct DNA/RNA damage to pathogens while preserving host cell integrity
• UVA: Enhanced immune cell activation and phagocytic capacity
• Blue 450nm: Vasodilation, reduced inflammatory markers, improved blood flow
• Green 525nm: Blood rheology optimization, decreased viscosity, enhanced electrophoretic mobility
• Amber 590nm: Nitric oxide production, mood enhancement, anti-depression effects
• Red 675nm: Primary enzyme support (SOD, Catalase), mitochondrial energy optimization

Clinical Evidence: Transforming Medical Outcomes

Viral Infections - Breakthrough Results

• Hepatitis C: 44.9% peak viral load reduction in FDA Phase II trial (p=0.0048)
• COVID-19: 7-day hospital stay reduction with zero mortality rates
• Dengue/Zika: Complete resolution within 48 hours (Costa Rica clinical study)
• Long COVID: Significant symptom improvement with declining D-dimer levels

Bacterial Infections - Superior Efficacy

• Tuberculosis: 100% disease-free rate vs. 58.8% in control groups
• Sepsis: Historical 95%+ success rate across 6,500+ patients
• MRSA/Antibiotic-Resistant Strains: No reported resistance development
• Pneumonia: 24-76 hour symptom resolution

Autoimmune and Inflammatory Conditions

• Rheumatoid Arthritis: 70-92% improvement rates
• Asthma: Significant improvement in steroid-resistant cases
• Multiple Sclerosis: 14/26 patients showed good clinical response
• Psoriasis: Marked improvement in concurrent treatment cases

Cardiovascular Applications

• Peripheral Arterial Disease: 3x improvement in walking distance
• Thrombophlebitis: 24-48 hour clot resolution
• Enhanced oxygen utilization and delivery
• Significant blood viscosity reduction

Engineering Excellence: Technical Specifications

Advanced LED Array System

• 60 High-Power LEDs: Delivering precise wavelength targeting
• Wavelength Range: 253.7nm UVC to 675nm Red light
• Power Output: 60 watts across multiple visible wavelengths
• Treatment Duration: Optimized exposure protocols for maximum efficacy

User Interface and Controls

• Touchscreen Interface: Intuitive operation for clinical staff
• Pre-programmed Protocols: Evidence-based treatment parameters
• Real-time Monitoring: Continuous treatment parameter display
• Safety Interlocks: Multiple fail-safe mechanisms

Patented TRIVETTE™ Cuvette Design

• Triple quartz tube parallel arrangement
• 600% increased blood exposure time
• Comprehensive pathogen inactivation
• Optimal cellular activation

Note: This device is intended for use by qualified healthcare practitioners. Consult with your healthcare provider to determine if photobiomodulation therapy is appropriate for your individual needs